Using multiplexed immunohistochemistry, C1Q+TREM-2+ TAMs were found to be tumor-specific and C1Q+TREM-2+APOE+ TAMs located significantly nearer the tumor cells than triple-negative TAMs. This evidence concerns the gene APOE and neoplasm.